Willem Lybaert

Brasschaat, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12-year retrospective analysis within NETwerk, an ENETS center of excellence.

Germline MEN1 testing patterns in patients with neuroendocrine tumors: A 12-year retrospective analysis within NETwerk, an ENETS center of excellence.

Journal: Journal of neuroendocrinology

Published: March 19, 2026

Shaping next decade of systemic therapy for head and neck squamous cell carcinoma: where do we go next?

Shaping next decade of systemic therapy for head and neck squamous cell carcinoma: where do we go next?

Journal: Frontiers in oncology

Published: January 29, 2026

Efficacy and safety of capecitabine-temozolomide (CAPTEM) regimen in patients with neuroendocrine neoplasms - experience from NETwerk, a Belgian ENETS Center of Excellence.

Efficacy and safety of capecitabine-temozolomide (CAPTEM) regimen in patients with neuroendocrine neoplasms - experience from NETwerk, a Belgian ENETS Center of Excellence.

Journal: Acta gastro-enterologica Belgica

Published: June 12, 2025

Dynamics in experiences, information and counselling needs of patients without or with minor LARS after rectal cancer surgery.

Dynamics in experiences, information and counselling needs of patients without or with minor LARS after rectal cancer surgery.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: February 09, 2025

Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol.

Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol.

Journal: BMC surgery

Published: November 13, 2024

Comparison of inter- and intraobserver agreement between [18F]AlF-NOTA-octreotide and [68Ga]Ga-DOTA-SSA PET/CT.

Comparison of inter- and intraobserver agreement between [18F]AlF-NOTA-octreotide and [68Ga]Ga-DOTA-SSA PET/CT.

Journal: EJNMMI reports

Published: October 28, 2024

Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.

Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.

Journal: Scientific reports

Published: September 23, 2024

Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

Journal: Endocrine-related cancer

Published: August 31, 2024

Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS).

Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS).

Journal: ESMO gastrointestinal oncology

Published: June 05, 2024

Clinical impact of using [18F]AlF-NOTA-octreotide PET/CT instead of [68Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.

Clinical impact of using [18F]AlF-NOTA-octreotide PET/CT instead of [68Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.

Journal: Journal of neuroendocrinology

Published: February 05, 2024

The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.

The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.

Journal: Current treatment options in oncology

Published: October 24, 2023

High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study.

High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study.

Journal: Nutrients

Published: September 29, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026